Shadow of the Future: Precision Medicine in Multiple Myeloma
Precision prescribing with pharmacogenomics
Personalized Medicine’s Path to Patients
Precision medicine approaches in sickle cell disease
Smarter, Accessible Data Means Learning from Every Patient
Informatics Approach and Considerations that Enable Precision Medicine Program Success
Women Leaders in Healthcare: Benefits of Diversity within Precision Medical Leadership
Rethinking patient education in oncology in the age of precision medicine
The current state of molecular testing
Opportunities to Advance Precision Medicine with Blockchain Powered AI
Is your organization “precision-medicine workforce ready”?
Raising the Bar: FDA Accelerates the Push Toward Personalized Medicine
Will DAIA resolve the ambiguities of regulating in vitro clinical tests?
Are your Companion Diagnostic Partners Ready?
Why Diagnostics Have Trouble Finding Their Voice
Immunothrapy: Predicting response to targeted therapies and checkpoint inhibitors
The Dawn of Personalized Medicine: The Role of the Pharmacist
Preventative medicine: genetic screening of inherited diseases
Direct-to-Consumer Genetic Testing is Disrupting Our Healthcare System by Empowering Consumers.
An Unlikely Alliance – Could PBMs and diagnosis labs find synergies in the healthcare market?
The Challenges of Patenting Precision Medicine in the Era of Mayo and Myriad
Takeda using Advanced Machine Learning to find insights about NASH & TRD
Enabling Genomics – Guided Precision Medicine with Real World Evidence
Neurodegenerative diseases and the microbiome: lessons learned from mouse models
Tweets
Efficient tissue removal and time to fixation are essential in maintaining tissue quality. #PrecisionMedicine… https://t.co/mzFyD7Lmiw, - Specialists performing biopsies should obtain an adequate amount of tissue for biomarker testing needs.… https://t.co/hQoXbG1NKn,
- Several factors should be considered in order to provide optimal testing processes with a pathology-driven… https://t.co/xccusP7DIZ,
